Index S&P 500
P/E 16.41
EPS (ttm) 5.49
Insider Own 23.35%
Shs Outstand 1.63B
Perf Week -1.71%
Market Cap 147.31B
Forward P/E 12.02
EPS next Y 7.50
Insider Trans -0.08%
Shs Float 1.25B
Perf Month 2.41%
Income 8.96B
PEG 2.05
EPS next Q 1.66
Inst Own 62.48%
Short Float 1.21%
Perf Quarter 6.72%
Sales 99.76B
P/S 1.48
EPS this Y 30.06%
Inst Trans -1.02%
Short Ratio 1.69
Perf Half Y 14.42%
Book/sh 55.50
P/B 1.62
EPS next Y 11.25%
ROA 0.76%
Short Interest 15.13M
Perf Year 0.88%
Cash/sh -
P/C -
EPS next 5Y 8.00%
ROE 9.12%
52W Range 69.42 - 95.57
Perf YTD -3.40%
Dividend Est. 3.51 (3.90%)
P/FCF 16.13
EPS past 5Y 1.84%
ROI 2.55%
52W High -5.74%
Beta 1.40
Dividend TTM 3.33 (3.69%)
Quick Ratio -
Sales past 5Y 15.18%
Gross Margin -
52W Low 29.76%
ATR (14) 2.39
Dividend Ex-Date Jan 30, 2024
Current Ratio 1.37
EPS Y/Y TTM -5.92%
Oper. Margin 12.42%
RSI (14) 50.18
Volatility 3.95% 2.38%
Employees 80000
Debt/Eq 3.63
Sales Y/Y TTM 34.52%
Profit Margin 8.98%
Recom 2.35
Target Price 96.63
Option/Short Yes / Yes
LT Debt/Eq 2.54
EPS Q/Q 18.45%
Payout 62.71%
Rel Volume 1.06
Prev Close 89.14
Sales Surprise 5.11%
EPS Surprise 20.83%
Sales Q/Q 13.33%
Earnings Apr 16 BMO
Avg Volume 8.96M
Price 90.08
SMA20 -1.41%
SMA50 1.82%
SMA200 5.61%
Trades
Volume 9,537,513
Change 1.05%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-17-24 Downgrade
Keefe Bruyette
Outperform → Mkt Perform
$102 → $91
Jan-17-24 Downgrade
JP Morgan
Overweight → Neutral
$94 → $87
Jan-09-24 Downgrade
HSBC Securities
Buy → Hold
$96
Nov-28-23 Downgrade
Societe Generale
Buy → Hold
Nov-20-23 Downgrade
Exane BNP Paribas
Outperform → Neutral
$85
Oct-23-23 Downgrade
Odeon
Buy → Hold
$79.15
Oct-20-23 Upgrade
Wolfe Research
Underperform → Peer Perform
Oct-11-23 Downgrade
UBS
Buy → Neutral
$110 → $84
Sep-07-23 Initiated
HSBC Securities
Buy
$99
Jul-12-23 Upgrade
Odeon
Hold → Buy
$94
Jan-18-23 Downgrade
Citigroup
Buy → Neutral
$100
Jan-10-23 Upgrade
Odeon
Sell → Hold
$88.75
Jan-04-23 Downgrade
Wolfe Research
Outperform → Underperform
$92
Oct-05-22 Downgrade
Atlantic Equities
Overweight → Neutral
$95 → $85
Sep-06-22 Downgrade
Odeon
Hold → Sell
May-03-22 Upgrade
Oppenheimer
Perform → Outperform
$111
Jan-28-22 Downgrade
Odeon
Buy → Hold
Dec-03-21 Upgrade
Citigroup
Neutral → Buy
$105 → $115
Oct-15-21 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$97
Oct-04-21 Reiterated
Jefferies
Buy
$108 → $119
Show Previous Ratings
Apr-17-24 05:08PM
04:33PM
03:13PM
09:56AM
08:50AM
08:11AM
Loading…
08:11AM
07:42AM
07:41AM
04:12AM
04:00AM
02:40AM
01:46AM
Apr-16-24 10:58PM
10:41PM
10:31PM
04:56PM
Loading…
04:56PM
04:24PM
(The Wall Street Journal)
01:45PM
(The Wall Street Journal)
12:30PM
12:19PM
12:05PM
12:00PM
(The Wall Street Journal)
11:52AM
11:52AM
11:06AM
11:02AM
11:02AM
10:53AM
(The Wall Street Journal)
10:48AM
10:24AM
(The Wall Street Journal)
10:23AM
Loading…
10:23AM
10:08AM
10:04AM
(The Wall Street Journal)
10:00AM
(The Wall Street Journal)
09:51AM
09:50AM
09:49AM
(Investor's Business Daily)
09:47AM
09:43AM
(The Wall Street Journal)
09:43AM
09:38AM
(The Wall Street Journal)
09:30AM
09:20AM
09:16AM
09:02AM
08:51AM
08:51AM
08:41AM
08:40AM
08:07AM
08:06AM
07:50AM
07:34AM
07:34AM
07:30AM
07:30AM
07:19AM
Apr-15-24 06:54PM
04:46PM
03:58PM
10:22AM
07:37AM
07:30AM
07:29AM
01:13AM
Apr-14-24 09:30AM
12:06AM
Apr-13-24 12:12PM
Apr-12-24 06:15PM
04:44PM
03:57PM
01:41PM
07:51AM
07:30AM
07:15AM
07:15AM
07:15AM
Apr-11-24 09:33PM
07:30PM
06:50PM
04:58PM
04:51PM
(Investor's Business Daily)
04:49PM
04:20PM
(The Wall Street Journal)
03:33PM
(The Wall Street Journal)
03:08PM
02:43PM
02:22PM
02:19PM
02:14PM
09:15AM
09:00AM
05:30AM
(The Wall Street Journal)
02:21AM
Apr-10-24 02:44PM
10:10AM
09:58AM
08:45AM
08:42AM
Apr-09-24 01:32PM
Provides diversified financial services including brokerage, investment management and venture capital services
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
GORMAN JAMES P Executive Chairman Feb 12 '24 Sale 87.30 100,000 8,730,220 350,000 Feb 14 04:19 PM SAPERSTEIN ANDREW M Co-President Feb 12 '24 Sale 87.19 26,655 2,324,092 286,835 Feb 14 04:19 PM GROSSMAN ERIC F Chief Legal/Admin Officer Jan 31 '24 Sale 88.55 26,562 2,352,001 234,627 Feb 01 04:20 PM GROSSMAN ERIC F Chief Legal/Admin Officer Jan 30 '24 Sale 87.81 26,563 2,332,595 261,189 Feb 01 04:20 PM SAPERSTEIN ANDREW M Co-President Jan 30 '24 Sale 87.92 10,000 879,170 313,490 Feb 01 04:22 PM AKRAM RAJA Deputy Chief Financial Officer Jan 30 '24 Sale 87.41 4,500 393,346 93,134 Feb 01 04:21 PM GORMAN JAMES P Executive Chairman Jan 26 '24 Sale 87.93 50,000 4,396,400 379,701 Jan 26 04:36 PM GORMAN JAMES P Executive Chairman Jan 25 '24 Sale 87.93 50,000 4,396,435 400,000 Jan 25 04:03 PM SAPERSTEIN ANDREW M Co-President Jan 19 '24 Sale 84.13 10,000 841,344 323,490 Jan 19 04:15 PM AKRAM RAJA Deputy Chief Financial Officer Jan 18 '24 Sale 83.56 7,000 584,928 97,634 Jan 19 04:22 PM MORGAN STANLEY 10% Owner Oct 05 '23 Sale 50000.00 135 6,750,000 0 Oct 10 08:22 PM GORMAN JAMES P Chairman and CEO Jul 24 '23 Sale 95.19 125,000 11,898,812 1,011,345 Jul 26 04:11 PM PICK EDWARD N Co-President/Head of IS Jul 24 '23 Sale 94.33 100,000 9,433,050 604,845 Jul 26 04:14 PM SIMKOWITZ DANIEL A Head of Investment Management Jul 20 '23 Sale 93.78 37,608 3,526,852 319,040 Jul 21 04:18 PM GORMAN JAMES P Chairman and CEO Jul 19 '23 Sale 92.35 125,000 11,543,286 1,136,345 Jul 21 04:13 PM SAPERSTEIN ANDREW M Co-President/Head of WM Jul 19 '23 Sale 93.09 39,254 3,654,280 193,708 Jul 21 04:16 PM AKRAM RAJA Deputy Chief Financial Officer Jul 19 '23 Sale 92.00 13,500 1,242,000 82,984 Jul 21 04:11 PM Smith Charles Aubrey III Chief Risk Officer Jul 19 '23 Sale 92.41 5,600 517,520 136,513 Jul 21 04:20 PM MORGAN STANLEY 10% Owner Jun 09 '23 Sale 9.45 1,049,889 9,921,451 8,456,881 Jun 13 04:04 PM AKRAM RAJA Deputy Chief Financial Officer May 15 '23 Sale 82.95 7,320 607,198 96,484 May 17 04:08 PM GLOCER THOMAS H Director May 03 '23 Sale 87.11 4,535 395,021 98,110 May 05 04:16 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite